Kite Pharma, Inc., (Nasdaq:KITE) today announced that management will participate in a panel at the 11th Annual Citi Biotech Conference and a fireside chat discussion at the Morgan Stanley Global Healthcare Conference.

• 11th Annual Citi Biotech Conference

   

o Date: Wednesday, September 7, 2016

o Time: 2:00 PM Eastern Time

o Location: Boston, MA

• Morgan Stanley Global Healthcare Conference

   

o Date: Tuesday, September 13, 2016

o Time: 1:30 PM Eastern Time

o Location: New York, NY

A live audio webcast of each event will be available on the Investors section of Kite’s website, www.kitepharma.com. A replay of each webcast will be available on the website for approximately 30 days.

About Kite Pharma

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

Kite PharmaGreg MannVP, Investor Relationsgmann@kitepharma.comorFor Media:inVentiv HealthDavid Polk, 310-309-1029david.polk@inventivhealth.com

KITE PHARMA, INC. (NASDAQ:KITE)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more KITE PHARMA, INC. Charts.
KITE PHARMA, INC. (NASDAQ:KITE)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more KITE PHARMA, INC. Charts.